PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain-Reference-Cited by-同舟云学术

PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain

Published:2009-05 Issue:5 Volume:15 Page:376-388
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Lambert Jeremy M.R.,Gorzov Petr,Veprintsev Dimitry B.,Söderqvist Maja,Segerbäck Dan,Bergman Jan,Fersht Alan R.,Hainaut Pierre,Wiman Klas G.,Bykov Vladimir J.N.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference34 articles.

1. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation;Bass;J. Immunol.,1983

2. Mutant p53-dependent growth suppression distinguishes PRIMA-1 from known anticancer drugs: a statistical analysis of information in the National Cancer Institute database;Bykov;Carcinogenesis,2002

3. Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound;Bykov;Nat. Med.,2002

4. Reactivation of Mutant p53 and Induction of Apoptosis in Human Tumor Cells by Maleimide Analogs;Bykov;J. Biol. Chem.,2005

5. PRIMA-1(MET) synergizes with cisplatin to induce tumor cell apoptosis;Bykov;Oncogene,2005

Cited by 483 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyrimidine Triones as Potential Activators of p53 Mutants;Biomolecules;2024-08-08

2. An engineered DNA aptamer-based PROTAC for precise therapy of p53-R175H hotspot mutant-driven cancer;Science Bulletin;2024-07

3. Evaluation of a Covalent Library of Diverse Warheads (CovLib) Binding to JNK3, USP7, or p53;Drug Design, Development and Therapy;2024-07

4. ASAH1 facilitates TNBC by DUSP5 suppression-driven activation of MAP kinase pathway and represents a therapeutic vulnerability;Cell Death & Disease;2024-06-26

5. Oncogenes and tumor suppressor genes: functions and roles in cancers;MedComm;2024-05-31